Estados financieros detallados de InflaRx N.V. (IFRX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 482.0%, margen operativo 3622.7%, margen neto 3875.3%.
Al precio actual de $2.04, IFRX presenta beneficios negativos (P/E no significativo) y un ROE del -58.00%. La capitalización bursátil es de $300M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $63089 | $165789 | $29331 |
| Coste de Ventas | $35658 | $66691 | $179570 | 0 | 0 | 0 | 0 | $532262 | $3.3M | $7.3M |
| Beneficio Bruto | -$35658 | -$68420 | -$179570 | 0 | 0 | 0 | 0 | -$469173 | -$3.2M | -$7.2M |
| I+D | $5.3M | $14.4M | $25.0M | $44.6M | $25.7M | $35.7M | $37.5M | $41.0M | $35.4M | $25.7M |
| Generales y Administrativos | $1.8M | $5.1M | $12.8M | $12.5M | $7.9M | $11.4M | $14.3M | $16.1M | $19.3M | $17.6M |
| Gastos Operativos | $6.9M | $18.8M | $37.5M | $56.8M | $33.9M | $47.6M | $32.2M | $44.1M | $49.8M | $41.0M |
| Beneficio Operativo | -$6.9M | -$19.4M | -$37.5M | -$56.8M | -$33.9M | -$47.6M | -$32.2M | -$44.6M | -$52.9M | -$48.3M |
| EBITDA | -$7.1M | -$19.6M | -$37.3M | -$56.5M | -$33.6M | -$44.9M | -$28.8M | -$42.1M | -$45.6M | -$45.2M |
| Gastos por Intereses | $1.8M | $2.2M | 0 | $22200 | $26000 | $24769 | $45250 | $35628 | $20655 | $37690 |
| Beneficio Antes de Impuestos | -$8.9M | -$24.2M | -$29.8M | -$53.3M | -$34.0M | -$45.6M | -$29.5M | -$42.7M | -$46.1M | -$45.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $5217 | $12282 |
| Beneficio Neto | -$8.9M | -$24.2M | -$29.8M | -$53.3M | -$34.0M | -$45.6M | -$29.5M | -$42.7M | -$46.1M | -$45.6M |
| BPA | $-0.38 | $-1.03 | $-1.19 | $-1.91 | $-1.26 | $-1.10 | $-0.61 | $-0.78 | $-0.78 | $-0.66 |
| BPA Diluido | $-0.38 | $-1.03 | $-1.19 | $-1.91 | $-1.26 | $-1.10 | $-0.61 | $-0.78 | $-0.78 | $-0.66 |
| Acciones en Circulación (Diluidas) | $23.4M | $23.6M | $25.1M | $26.0M | $27.1M | $41.6M | $44.2M | $54.9M | $58.9M | $67.3M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $29.1M | $123.3M | $55.4M | $33.1M | $26.0M | $26.2M | $16.3M | $12.8M | $18.4M | $16.0M |
| Inversiones a Corto | 0 | 0 | $101.2M | $82.4M | $55.2M | $57.2M | $65.5M | 0 | 0 | $30.4M |
| Cuentas por Cobrar | 0 | $120000 | 0 | 0 | 0 | $1.3M | $1.4M | 0 | 0 | $1.4M |
| Inventario | $31000 | $504000 | 0 | 0 | 0 | 0 | 0 | $11.4M | $6.9M | 0 |
| Activos Corrientes | $29.4M | $124.0M | $158.2M | $119.0M | $86.3M | $95.7M | $97.4M | $109.5M | $71.7M | $53.6M |
| Inmovilizado Material | $131000 | $173000 | $625000 | $1.4M | $954957 | $1.7M | $1.6M | $1.4M | $1.0M | $1.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $5000 | $41000 | $223000 | $452400 | $350183 | $235216 | $138905 | $42841 | $7263 | $42236 |
| Activos Totales | $29.5M | $124.2M | $159.2M | $121.6M | $88.2M | $125.1M | $102.4M | $120.2M | $76.0M | $55.2M |
| Cuentas por Pagar | $1.5M | $4.5M | $6.7M | $12.4M | $1.7M | $1.7M | $5.0M | $5.1M | $3.4M | $5.4M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $256833 |
| Pasivos Corrientes | $1.7M | $4.8M | $7.8M | $14.1M | $10.1M | $18.8M | $13.0M | $16.8M | $14.2M | $13.0M |
| Deuda a Largo | $53.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $55.2M | $4.8M | $7.8M | $14.4M | $10.4M | $19.9M | $14.1M | $17.6M | $14.6M | $13.7M |
| Reservas | -$27.1M | -$51.3M | -$81.1M | -$134.4M | -$168.3M | -$214.0M | -$243.5M | -$286.1M | -$332.2M | -$377.7M |
| Patrimonio Neto | -$25.7M | $119.4M | $151.4M | $107.1M | $77.9M | $105.3M | $88.3M | $102.6M | $61.4M | $41.5M |
| Deuda Total | $53.4M | 0 | 0 | $845948 | $559041 | $1.4M | $1.4M | $1.1M | $805086 | $897532 |
| Deuda Neta | $24.3M | -$123.3M | -$156.6M | -$114.6M | -$80.6M | -$82.0M | -$80.5M | -$11.6M | -$17.6M | -$45.5M |
| Capital Circulante | $27.6M | $119.2M | $150.4M | $104.9M | $76.2M | $76.9M | $84.4M | $92.6M | $57.5M | $40.6M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$8.9M | -$24.2M | -$29.8M | -$53.3M | -$34.0M | -$45.6M | -$29.5M | -$42.7M | -$46.1M | -$43.8M |
| Amortizaciones | $33000 | $71000 | $174000 | $663166 | $712713 | $669434 | $596597 | $567780 | $485114 | $402926 |
| Compensación en Acciones | $868000 | $4.5M | $12.1M | $6.8M | $1.1M | $4.3M | $6.0M | $3.4M | $4.1M | 0 |
| Cambio en Capital Circulante | $1.2M | $2.6M | $1.8M | -$2.3M | -$5.3M | $1.5M | -$9.8M | $1.0M | -$2.3M | $4.7M |
| Flujo de Caja Operativo | -$5.0M | -$12.2M | -$23.7M | -$43.2M | -$36.5M | -$39.9M | -$33.7M | -$37.8M | -$48.6M | -$33.9M |
| Inversiones (CapEx) | -$53000 | -$149000 | -$806000 | -$594889 | -$94189 | -$37778 | -$162391 | -$81100 | -$46871 | -$111127 |
| Adquisiciones | 0 | 0 | $806000 | 0 | $94189 | $37778 | -$19.5M | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$5.0M | -$12.3M | -$24.5M | -$43.8M | -$36.6M | -$40.0M | -$33.9M | -$37.9M | -$48.6M | -$34.0M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +162.8% | -82.3% | ||||||||
| Crecimiento Beneficio Neto (anual) | -171.1% | -23.0% | -78.6% | +36.2% | -34.3% | +35.4% | -44.7% | -8.0% | +0.9% | |
| Crecimiento BPA (anual) | -171.1% | -15.5% | -60.5% | +34.0% | +12.7% | +44.5% | -27.9% | +0.0% | +15.4% | |
| Cambio en Acciones (anual) | +0.9% | +6.3% | +3.6% | +4.1% | +53.8% | +6.2% | +24.3% | +7.2% | +14.2% | |
| Crecimiento FCF (anual) | -143.8% | -99.3% | -78.6% | +16.4% | -9.2% | +15.2% | -11.8% | -28.3% | +30.0% | |
| Margen Bruto | -743.7% | -1900.8% | -24677.9% | |||||||
| Margen Operativo | -70685.6% | -31911.4% | -164525.5% | |||||||
| Margen EBITDA | -66674.3% | -27476.7% | -153976.3% | |||||||
| Margen Neto | -67630.7% | -27785.0% | -155582.1% | |||||||
| Margen FCF | -60064.5% | -29316.5% | -116026.4% | |||||||
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-0.22 | $-0.52 | $-0.98 | $-1.68 | $-1.35 | $-0.96 | $-0.77 | $-0.69 | $-0.82 | $-0.51 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $23.4M | $23.6M | $25.1M | $26.0M | $27.1M | $41.6M | $44.2M | $54.9M | $58.9M | $67.3M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -58.00% |
| Rentabilidad sobre capital invertido | -24.89% |
| Rentabilidad sobre activos | -23.46% |
| Margen bruto | 48201.61% |
| Margen operativo | 362271.47% |
| Margen neto | 387532.08% |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 8.22 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -37.48 | -16.34 | -26.65 | -1.85 | -3.27 | -3.81 | -4.75 | -1.89 | -3.06 | -1.30 |
| P/VC | -12.98 | 3.33 | 5.26 | 0.86 | 1.43 | 1.66 | 1.45 | 0.79 | 2.29 | 1.39 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1284.19 | 847.69 | 1972.04 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -743.7% | -1900.8% | -24677.9% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -70685.6% | -31911.4% | -164525.5% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -67630.7% | -27785.0% | -155582.1% |
Empresas relacionadas: ARTV · ATYR · CNTB · CNTX · IMA · KLRS · MGX
Explorar sector: Healthcare · Biotechnology
Más secciones de IFRX: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones